ArticleJCO oncology practice2023
Integrated Radiology, Pathology, and Pharmacy Program to Accelerate Access to Osimertinib.
Ibiayi Dagogo-Jack et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it